Drug intelligence / Profile preview

dithiodesmethyl carbodenafil

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Dithiodesmethyl carbodenafil is a synthetic small molecule analogue of sildenafil (Viagra) that acts as a phosphodiesterase-5 (PDE-5) inhibitor. It is not an approved pharmaceutical drug but is frequently identified as an undeclared illegal adulterant in dietary supplements marketed for male sexual enhancement. Structurally, it features a thiocarbonyl-thiolactam skeleton and shares the same pharmacological mechanism as approved PDE-5 inhibitors, which involves increasing cyclic guanosine monophosphate (cGMP) levels to promote smooth muscle relaxation and increased blood flow to the corpus cavernosum. Its presence in supplements poses significant health risks, particularly the potential for life-threatening hypotension when combined with nitrates. The FDA has issued multiple warnings and recalls for products containing this compound.

Other names
dithio-desmethyl-carbodenafildithiodesmethylcarbodenafil
02

Targets

PDE5 (Phosphodiesterase 5A)

Beyond the preview

Go deeper on dithiodesmethyl carbodenafil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dithiodesmethyl carbodenafil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call